Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 04 - 25 symbols : Nvsef save search
Ontario and Quebec become the first provinces to list Kesimpta (ofatumumab) for the treatment of adults with relapsing remitting multiple sclerosis (RRMS)
Published: 2022-04-25 (Crawled : 14:00) - biospace.com/
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
treatment sclerosis multiple sclerosis
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200
|
Health Technology
|
| O: -2.78%
H: 0.0%
C: 0.0%
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: -0.11%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
MNKKQ | $0.02
|
Manufacturing
|
| O: -2.96%
H: 2.29%
C: -6.57%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -0.1%
H: 0.35%
C: -0.09%
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
|
| O: -5.01%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -1.57%
H: 1.5%
C: 1.39%
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: -4.95%
H: 2.32%
C: 1.9%
BHC | $8.53 0.95% 0.0% 4M
|
Health Technology
|
| O: -3.12%
H: 0.37%
C: 0.19%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -2.17%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
NMRD | $0.072 -28.78% 43K
|
Health Technology
|
| O: 17.02%
H: 0.52%
C: -2.6%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -1.38%
H: 0.65%
C: 0.46%
device disease
Hyperalgesia Drugs in Development Report 2022: Featuring Caventure Drug Discovery, Charleston Laboratories, Exodos Life Sciences and Novartis
Published: 2022-04-25 (Crawled : 11:00) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
drug report novartis
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.